JPRN-UMIN000015223已完成未知
The effect of lanthanum carbonate on hyperphosphatemia in chronic kidney disease patients not on dialysis. - ELAC-Hyper-CKD (Effect of LAnthanum Carbonate on Hyperphosphatemia in Chronic Kidney Disease patients)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)<20years old 2)Malignancy of any type 3)Contraindications to lanthanum carbonate 4)Diabetes mellitus 5)Renal transplant 6)Pregnant or breast-feeding women 7)Ineligible patients for this study according to the investigator's judgment
研究者
相似试验
尚未招募
不适用
Effect of lanthanum carbonate on serum levels of calcification inhibitor fetuin-A in hemodialysis patientsChronic kidney diseaseJPRN-UMIN000010730Department of urology, school of medicine,yamaguchi university50
已完成
1 期
Healthy Combine StudyHealthyNCT03136705Northwestern University39
已完成
4 期
Study on the impact of lanthanum carbonate on FGF23 in chronic kidney diseaseChronic Kidney DiseaseJPRN-UMIN000015188Daiko-Sunadabashi Clinic100
已完成
不适用
Fosrenol and Phosphorus Balance - Lanthanum CarbonateChronic Kidney FailureEnd-stage Renal DiseaseDisorders Associated With Peritoneal DialysisNCT01581996Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center9
已完成
3 期
Outcome study of Lanthanum Carbonate compared with Calcium carbonate on cardiovascular mortality and morbidity in patients with chronic kidney disease on hemodialysis: Landmark StudyHemodialysis patients with hyperphosphatemiaJPRN-UMIN000006815andmark Study Group2,347